Maureen F Zakowski, MD

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Scopus h-index:71

Article:141

Review Article:12

Comment/Debate:5

Letter:2

Chapter:1

Recent Artifacts

• The World Health Organization Reporting System for Lung Cytopathology
• Melanotic medullary thyroid carcinoma: A case report with review of the literature
• New or enlarging hiatal hernias after thoracic surgery for early lung cancer
• A comparative study of the genotype profiles of high-risk human papillomavirus infection in male and female HIV-positive patients and their correlation with anal cytology and biopsy
• Building a smart FNA cart: When Google meets cytology
• Change in quality of life of stage IA lung cancer patients after sublobar resection and lobectomy
• Cytological features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)
• Initiative for Early Lung Cancer Research on Treatment: Development of Study Design and Pilot Implementation
• Analytic inquiry: Molecular testing in lung cancer
• “…That which we call a rose…”: A critical analysis of rapid on-site evaluation

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Zakowski did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.